BC Innovations | Feb 5, 2015
Distillery Therapeutics

Therapeutics: Kruppel-like factor 10 (KLF10)

Cancer INDICATION: Cancer In vitro studies suggest a new KLF10 inhibitor could help improve the efficacy of cancer immunotherapy. The transcription factor KLF10 regulates conversion of T cells into T regulatory cells (Tregs) that suppress...
Items per page:
1 - 1 of 1